Is reduced right ventricular power after sotatercept beneficial ?

Genecand, Léon; Boucly, Athénaïs; Sitbon, Olivier; Chemla, Denis; Montani, David

doi:10.1016/j.healun.2026.06.010

Scientific article

Letter

English

Is reduced right ventricular power after sotatercept beneficial ?

ContributorsGenecand, Léon

; Boucly, Athénaïs; Sitbon, Olivier; Chemla, Denis; Montani, David

Published inThe Journal of heart and lung transplantation

First online date2026-06-19

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Maladies interstitielles et de l'immunodéprimé (1057)

Citation (ISO format)

GENECAND, Léon et al. Is reduced right ventricular power after sotatercept beneficial ? In: The Journal of heart and lung transplantation, 2026. doi: 10.1016/j.healun.2026.06.010

Article (Published version)

Article (Accepted version)

20/06/2027

Identifiers

PID : unige:195266
DOI : 10.1016/j.healun.2026.06.010
PMID : 42320807

Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S1053249826019546

Journal ISSN1053-2498

1views

0downloads

Creation28/07/2026 09:01:44

First validation14/08/2026 09:14:49

Update14/08/2026 09:14:49

Status update14/08/2026 09:14:49

Last indexation14/08/2026 09:14:50

Archive ouverte UNIGE

Is reduced right ventricular power after sotatercept beneficial ?

Technical informations